The Efficacy of Transarterial Chemoinfusion (TAI) Combine Lenvatinib in Advanced Hepatocellular Carcinoma (HCC)
Clinical trial NCT04053985 · UNKNOWN
Trial details
- NCT number
- NCT04053985
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-01
- Primary completion
- 2022-12-31
- Enrollment
- 206
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.